Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.
about
Interventional therapies for hepatocellular carcinomaLocoregional drug delivery using image-guided intra-arterial drug eluting bead therapyMinimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.Development of "imageable" beads for transcatheter embolotherapy.Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survivalTumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model.Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.Angiographic evaluation of hepatic arterial injury after cisplatin and Gelfoam-based transcatheter arterial chemoembolization for hepatocellular carcinoma in a 205 patient cohort during a 6-year follow-upThe effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: gelfoam versus polyvinyl alcohol.Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteriaHypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance ImagingTACE versus TAE as therapy for hepatocellular carcinoma.Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomesNonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?Preoperative portal venous and hepatic arterial embolization of tumorQuantitative assessment of angiographic perfusion reduction using color-coded digital subtraction angiography during transarterial chemoembolization.Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.Calibrated Bioresorbable Microspheres as an Embolic Agent: An Experimental Study in a Rabbit Renal Model.Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water.Therapeutic effects of transarterial infusion of lipiodol and ethanol in various ratios in a rabbit VX2 tumor modelEvaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver.Chemoembolization-induced arterial damage: Evaluation of three different chemotherapeutic protocols using epirubicin and miriplatin.A preclinical study of the safety and efficacy of Occlusin™ 500 Artificial Embolization Device in sheep.Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
P2860
Q26864803-2EFF5355-8658-49FC-89D7-DF266934E186Q27015918-D08E5286-1131-44F7-9586-80487306B9D6Q30468280-CCD3E287-632F-4A96-BA31-27BEEEEF9C5AQ31036824-0A5B9515-E183-466E-8B35-DF3E47DFF173Q33876358-03D64484-2227-421C-9F8F-E5C709570875Q33925521-EDEDD7F4-3B7F-4EF7-AD61-1967A1C6EFB5Q34185914-64BB24C2-54EA-4D08-A389-61981717A25FQ35163735-6E2CE937-76AE-44E9-BD06-979D924EBCAEQ35168279-1FA3206C-7F09-47A4-85B2-9816A71A3161Q35322713-094AEBDE-372C-41E4-9D13-FC868F7662D5Q35452809-01C80557-6C15-4363-A820-C3AFA1D45780Q35676697-2E13CE45-D6F7-48F0-BB35-BB9AA47B6139Q35720583-9A82554E-FC90-4700-B625-7054EB948D95Q35988578-4F705E38-F7E7-4A7F-8BF3-695970569D4AQ36573406-9B983655-24FD-4752-9AC2-89C4AAF0B6CCQ37039550-66F3AB0F-0100-40F8-A55D-C67663D062BEQ37221919-A635AF47-DCCD-4EFC-80C4-404F2B7F36DCQ37300023-5BD5FE95-C7AA-4D0D-9239-56DCD738EE4DQ37369324-118357BE-1D03-40E5-9677-5639ABA15589Q37669068-3E86AAEC-09FA-4C66-920D-2746BF285E93Q37768896-F5ECBA26-A84C-4595-8598-C7E0F00CE6CCQ37808643-1C163A69-A661-45F2-A739-AB92C2CC1F60Q39210533-05D7465B-3E93-4F19-BA85-467AB49C4EFBQ40363852-5E1979F1-A095-4397-AD9D-C567A47C4B9AQ40499216-BF0FB10B-FCDA-4FE3-93C6-62ECB33D50DAQ41297789-CC8AA713-C0B3-438A-8441-41168755D9BBQ41405406-E957C53D-B34E-4CE2-A946-A1301659255FQ42532373-DF051662-688E-4E2C-A19B-ABF6EA896FDEQ42560359-B2B615ED-0DC6-49B4-853A-2FD6A4D19654Q45342871-BD0942A5-9DFC-4B71-B789-AE3334EBADE7Q46212506-7E62C1D3-D561-499C-AA19-954F97C2F5D4Q53089236-6555D8E9-560A-4F98-8BC7-A5EC96332CD0
P2860
Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@en
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@nl
type
label
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@en
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@nl
prefLabel
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@en
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@nl
P2093
P1476
Transcatheter arterial chemoem ...... d subsequent arterial patency.
@en
P2093
B C H van der Wal
Berry Cleffken
Douglas E Ramsey
George G Hartnell
Hicham Kobeiter
Jean-Francois H Geschwind
Krishna Juluru
Michael A Choti
P2888
P304
P356
10.1007/S00270-002-2524-6
P577
2003-03-06T00:00:00Z